Table 2 Distribution of mycoestrogens in urine (ng/ml) and placenta (ng/g) in the UPSIDE cohort.

From: Sociodemographic and dietary predictors of maternal and placental mycoestrogen concentrations in a US pregnancy cohort

Analyte

Matrix

N

LOD

%>LOD

GM (GSD)a

Percentiles

Max

25th

50th

75th

95th

bZAL

Urine

774

0.018

30.4

—

<LOD

<LOD

0.028

0.105

1.713

bZAL

Placenta

271

0.006

13.7

—

<LOD

<LOD

<LOD

0.011

0.493

bZOL

Urine

774

0.028

47.8

—

<LOD

<LOD

0.072

0.248

1.545

bZOL

Placenta

271

0.007

8.1

—

<LOD

<LOD

<LOD

0.004

0.06

aZAL

Urine

774

0.015

21.4

—

<LOD

<LOD

<LOD

0.055

0.823

aZAL

Placenta

271

0.005

17

—

<LOD

<LOD

<LOD

0.009

0.771

aZOL

Urine

774

0.018

83.9

0.136 (2.917)

0.050

0.138

0.271

0.822

4.135

aZOL

Placenta

271

0.011

26.9

—

<LOD

<LOD

0.003

0.009

1.035

ZAN

Urine

774

0.010

16.1

—

<LOD

<LOD

<LOD

0.018

0.414

ZAN

Placenta

271

0.006

16.2

—

<LOD

<LOD

<LOD

0.006

0.816

ZEN

Urine

774

0.011

95.6

0.127 (2.743)

0.066

0.123

0.24

0.682

3.7

ZEN

Placenta

271

0.008

59.4

—

<LOD

0.005

0.013

0.027

0.203

SUM

Urine

774

0.010

97

0.295 (3.325)

0.159

0.323

0.617

1.662

9.443

SUM

Placenta

271

0.005

84.1

0.010 (2.975)

0.003

0.012

0.019

0.047

2.094

  1. The geometric mean was calculated only for analytes detected in more than 75% of specimens and concentrations below LOD were replaced with LOD/sqrt [2].
  2. aThe data reported for urine concentrations represents samples from all three trimesters.
  3. aZAL alpha-zearalanol, aZOL alpha-zearalenol, bZAL beta-zearalanol, bZOL beta-zearalenol, GM geometric mean, GSD geometric standard deviation, Max maximum, ZAN zearalanone, ZEN zearalenone, SUM sum of mycoestrogen analytes.
Back to article page